Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAslan, Figen
dc.contributor.authorAvcıkurt, Ayla Solmaz
dc.date.accessioned2021-02-15T09:45:09Z
dc.date.available2021-02-15T09:45:09Z
dc.date.issued2019en_US
dc.identifier.issn1340-6868
dc.identifier.issn1880-4233
dc.identifier.urihttps://doi.org/10.1007/s12282-019-00947-6
dc.identifier.urihttps://hdl.handle.net/20.500.12462/11061
dc.description.abstractBackgroundUpregulated gene 4 (URG4) is a recently described oncogene that upregulates cell proliferation. Its overexpression has been identified in many malignancies, and it is thought to be related to tumour progression, angiogenesis, metastasis and the recurrence of many cancers. This is the first study to show its expression in breast cancer patients and its association with clinicopathological characteristics in these patients.MethodsFifty invasive ductal breast carcinoma cases and 25 control cases were included in the study. Tumourous tissues and control tissues were assessed molecularly for quantification of mRNA expression of URG4 and immunohistochemically for protein expression of URG4.ResultsThe mean ages of the patients and controls were 54.311.3 and 38.9 +/- 9.7 years, respectively. The expression levels of URG4 mRNA in tumour tissues were higher compared to control breast tissues (p=0.023). An immunohistochemical assessment suggested that URG4 is strongly expressed in normal breast tissues and lower-grade (grades I and II) ductal carcinomas of the breast, but it is weakly expressed in high-grade (grade III) ductal breast carcinomas. Additionally, the immunohistochemical and molecular expression results of URG4 were relevant to most prognostic parameters (tumour size, oestrogen and progesterone receptor status, HER2 status and Ki67 proliferative index) for breast cancer. However, unlike the immunohistochemical studies, the molecular studies revealed that there was no significant difference in URG4 expression for different grades of tumour tissues.Conclusion The literature data suggest that URG4 overexpression is associated with poor prognosis in many types of cancer. Conversely, our results in breast cancer specimens indicate that URG4 overexpression in breast ductal carcinomas is significantly associated with good prognostic parameters. Nevertheless, these preliminary findings should be confirmed by further studies.en_US
dc.description.sponsorshipBalikesir University Coordinator of Scientific Research Projecten_US
dc.language.isoengen_US
dc.publisherSpringer Japanen_US
dc.relation.isversionof10.1007/s12282-019-00947-6en_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectURG4en_US
dc.subjectURGCPen_US
dc.subjectBreast Canceren_US
dc.subjectmRNA Expressionen_US
dc.subjectProtein Expressionen_US
dc.titleURG4 expression in invasive breast carcinoma and its relation to clinicopathological characteristicsen_US
dc.typearticleen_US
dc.relation.journalBreast Canceren_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000-0002-4817-1904en_US
dc.identifier.volume26en_US
dc.identifier.issue4en_US
dc.identifier.startpage485en_US
dc.identifier.endpage491en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster